{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-23-000054","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.769382+00:00","generated_at":"2026-06-09T06:18:59.048181+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Tenet Q3 adj EPS $1.44; raises FY 2023 EBITDA outlook to $3.365-3.465B","bullets":["Net income $101M ($0.94 GAAP); adjusted diluted EPS $1.44 vs $1.42 YoY.","Revenue $5,066M (+5.5% YoY); consolidated Adj. EBITDA $854M (+$13M YoY).","Ambulatory Care Adj. EBITDA $370M (+16.0% YoY); same-facility surgical cases +4.1%.","FY 2023 Adj. EBITDA outlook raised to $3.365-3.465B; free cash flow $327M in Q3.","Repurchased 1.5M shares for $90M in nine months; net debt/EBITDA 4.08x."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-23-000054","json":"https://secwatch.observer/filing/0000070318-23-000054.json","markdown":"https://secwatch.observer/filing/0000070318-23-000054.md","text":"https://secwatch.observer/filing/0000070318-23-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000054/0000070318-23-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000054/thc-20231030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T06:18:59.048181+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eac5e42dc72407431edbef8bdb41b695ccdd610f","claim":"TENET HEALTHCARE CORP reported quarter ended September 30, 2023 results: revenue $5,066, net income $101 million, EPS $0.94. Guidance raised.","evidence_excerpt":"2022 are as follows: Three Months Ended September 30, Nine Months Ended September 30, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,066 $4,801 $15,169 $14,184 Net income available to Tenet common shareholders from continuing operations $101 $131 $367 $308 Net income available to Tenet common shareholders from","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000054/0000070318-23-000054-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended September 30, 2023"},{"label":"Revenue","value":"$5,066"},{"label":"Net income","value":"$101 million"},{"label":"EPS","value":"$0.94"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}